Synaptic Vesicle Density in Cannabis Dependence
Synaptic Vesicle Density in Cannabis Dependence
批准号:
9387557
负责人:
DEEPAK Cyril D'SOUZA
金额:
$25.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2019-08-31
关键词:
AbstinenceAcuteAdolescenceAdolescentAdultAffectAgeAge-YearsAlzheimer&aposs DiseaseAnimalsAnteriorAnticonvulsantsApplications GrantsAuditoryBindingBrainBrain imagingBrain regionCNR1 geneCannabinoidsCannabisChronicCognitionCognitive deficitsDataDevelopmentDistalElectroencephalographyElectrophysiology (science)EventExposure toFundingGlobus PallidusGlycoproteinsHippocampus (Brain)HistologicHumanImageIn VitroIndividualInsula of ReilKeppraKineticsLegalLevetiracetamLigand BindingLinkMagnetic Resonance ImagingMarijuana DependenceMeasuresMedialMedicalMembrane ProteinsMemoryMemory impairmentMetabolismMethodsModelingMorphologyOutcomeParahippocampal GyrusPenetrationPerceptionPeripheralPharmaceutical PreparationsPhasePopulationPositron-Emission TomographyProtein IsoformsProteinsProxyResearchResolutionRiskRodentSafetyScalp structureSchizophreniaSignal TransductionSpecificitySpicesStructureSurfaceSynapsesSynaptic VesiclesSynaptophysinTeenagersTemporal LobeTestingTracerVerbal LearningVertebral columnanalogcingulate cortexcognitive functiondensityearly adolescenceemerging adultgray matterillicit drug usein vivomarijuana legalizationmarijuana useneuropsychiatric disordernovelparametric imagingpostsynapticputamenradioligandrelating to nervous systemresponserisk perceptionsynthetic cannabinoidvirtualyoung adult
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY AND ABSTRACT
Background: Cannabis is the most commonly used illicit drug by young people. The potency of cannabis has
increased and so has the use of highly potent synthetic cannabinoids (`Spice'). Furthermore, the “medical” and
recreational use of cannabis is increasingly being legalized across the U.S.
Perceptions of the risks of
cannabis use amongst teenagers
has declined over the past decade
. The initiation of cannabis use typically
occurs during adolescence and young adulthood, when the brain is still developing and is most vulnerable to
insults, particularly drugs. Therefore, it is important to understand the consequences of chronic cannabinoid
exposure on the structure and function of the brain. Repeated administration of cannabinoids to both rodents
has been shown to lower synaptic density, but this has yet to be studies in humans. We recently developed
[11C]-UCB-J, a tracer for imaging of the synaptic vesicle protein SV2A in vivo. The purpose of this exploratory
study is to compare synaptic density in cannabis dependent subjects (CDs) and healthy controls (HCs) and to
relate changes in synaptic density to proximal and distal measures of brain activity, namely evoked ɣ
oscillations in the EEG and verbal memory. Furthermore, the relationship between [11C]-UCB-J binding,
evoked ɣ oscillations, verbal memory, and measures of cannabis exposure (age of first use and lifetime
exposure) will be explored.
Hypotheses: Compared to HCs, CDs will show 1) ↓ [11C]-UCB-J binding, 2) ↑ deficits in measures of evoked ɣ
oscillations, and 3) ↑ deficits in verbal memory. In CD subjects, lower [11C]UCB-J binding will be positively
correlated with earlier age of initiation of cannabis use, lifetime cannabis exposure, worse verbal memory and
greater deficits in ɣ oscillations.
Methods: We will compare synaptic density in CDs (n=12) vs. HCs (n=12) using
[11C]-
UCB-J and the High
Resolution Research Tomograph. CDs and HCs will also be compared on measures of evoked ɣ oscillations
(auditory steady state response: ASSR) and verbal memory (Rey Auditory Verbal Learning Task: RAVLT). The
relationship between
[11C]-
UCB-J binding, evoked ɣ oscillations, verbal memory, and measures of cannabis
exposure (age of initiation of use and lifetime exposure) will be explored.
Pilot data: To demonstrate feasibility, CDs (n=2) and HC (n=6) have been studied; CDs showed reduced
SV2A binding of 10% or more (i.e., greater than the margin of test-retest variability) in several brain regions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
-
批准号:10720412
-
项目类别:
-
资助金额:$58.91万
-
财政年份:2023
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
-
批准号:10426260
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain.
-
批准号:10284669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?
-
批准号:10280518
-
项目类别:
-
资助金额:$52.48万
-
财政年份:2021
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?
-
批准号:10670847
-
项目类别:
-
资助金额:$58.67万
-
财政年份:2021
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Preliminary studies of muscarinic M1 receptor availability and cognition in schizophrenia
-
批准号:10304204
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2020
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Preliminary studies of muscarinic M1 receptor availability and cognition in schizophrenia
-
批准号:10156577
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2020
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD)
-
批准号:9460794
-
项目类别:
-
资助金额:$318.49万
-
财政年份:2017
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
CB1R Availability in Synthetic Psychoactive Cannabinoid Users
-
批准号:9244957
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2017
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Intravenous Alcohol and THC Effects on Simulated Driving and Related Cognition
-
批准号:9116745
-
项目类别:
-
资助金额:$15.54万
-
财政年份:2015
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
FAAH-Inhibitor for Cannabis Dependence
-
批准号:8268029
-
项目类别:
-
资助金额:$51.91万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
-
批准号:8698400
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
FAAH-Inhibitor for Cannabis Dependence
-
批准号:8654326
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
-
批准号:8536592
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
FAAH-Inhibitor for Cannabis Dependence
-
批准号:9014590
-
项目类别:
-
资助金额:$11.77万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Imaging Brain Cannabinoid Receptors (CB1) in Schizophrenia
-
批准号:8441531
-
项目类别:
-
资助金额:$17.03万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
FAAH-Inhibitor for Cannabis Dependence
-
批准号:8468884
-
项目类别:
-
资助金额:$10.09万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
FAAH-Inhibitor for Cannabis Dependence
-
批准号:8466946
-
项目类别:
-
资助金额:$48.29万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Imaging Brain Cannabinoid Receptors (CB1) in Schizophrenia
-
批准号:8301970
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans
-
批准号:8793756
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DEEPAK Cyril D'SOUZA
-
依托单位:
海外基金